AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Soligenix, Inc.
Video analysis: SNGX
All videosNo video analysis for this stock yet. Request one from our team.
News: SNGX
Contrasting Zura Bio (NASDAQ:ZURA) and Soligenix (NASDAQ:SNGX)
Soligenix (NASDAQ: SNGX - Get Free Report) and Zura Bio (NASDAQ: ZURA - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation. Profitability This table compares Soligenix and Zura Bio's
Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results
PRINCETON, N.J., Aug. 7, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended June 30, 2026.
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.com, a leading investment platform for retail investors
Similar companies
-
Ensysce Biosciences, Inc.
ENSC
·
NASDAQ
Compare
-
Oragenics, Inc.
OGEN
·
New York Stock Exchange Arca
Compare
-
Can-Fite BioPharma Ltd.
CANF
·
New York Stock Exchange Arca
Compare
-
Kazia Therapeutics Ltd ADR
KZIA
·
NASDAQ
Compare
-
Xenetic Biosciences, Inc.
XBIO
·
NASDAQ
Compare
-
Silo Pharma, Inc.
SILO
·
NASDAQ
Compare